re: announcement -b2 Of course, the most pertinent question (at...

re: announcement -b2 Of course, the most pertinent question (at least that I can think of) is what portion of Mr G Solomon's time it is that he is being remunerated $150k pa for in the Eden context?

If 100%, that might be good value, but isn't he MD of a little company called Tasman Resources as well? And isn't he also running a legal practice?

Key issue is what proportion of shareholder's funds raised by the TAS group are shareholders willing be paid to Mr G Solomon and his cohorts?

This, and placement, all before assays of course. What do you think might be the problem of waiting until the assays come. Surely if the assays are good, shareholders will feel a bit more generous to Mr G Solomon than if assays are ordinary.

I remain a sceptic about this company/group and wonder just how shareholder friendly they might be.